Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 6 years
- Director since
- 2023
6 years of board service in total across 2 boards, counting each seat separately. Longest: Annovis Bio Inc., 3 years.
Annovis Bio Inc.
Director
Translational Development Acquisition Corp.
Director · Chairman and CEO
Chief executive roles
Translational Development Acquisition Corp.
· Chief Executive Officer
Since December 2024
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Annovis Bio Inc. June 17, 202694.0%
-
Annovis Bio Inc. June 17, 202595.3%
-
Annovis Bio Inc. June 13, 202496.9%
-
Annovis Bio Inc. June 16, 202399.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 20, 2026 | Annovis Bio Inc. | Open-market purchase | +2,562 | $1.75 | $4,484 |
| May 20, 2026 | Annovis Bio Inc. | Open-market purchase | +18,849 | $1.80 | $33,928 |
| May 20, 2026 | Annovis Bio Inc. | Open-market purchase | +54,933 | $1.90 | $104,373 |
| Apr 2, 2026 | Annovis Bio Inc. | Open-market purchase | +713,800 | $2.10 | $1,498,980 |
| Dec 8, 2025 | Annovis Bio Inc. | Open-market purchase | +30,000 | $4.34 | $130,200 |
| Dec 8, 2025 | Annovis Bio Inc. | Open-market purchase | +15,000 | $4.24 | $63,600 |
| Nov 24, 2025 | Annovis Bio Inc. | Open-market purchase | +1,489 | $4.13 | $6,150 |
| Nov 24, 2025 | Annovis Bio Inc. | Open-market purchase | +9,200 | $3.85 | $35,420 |
| Nov 24, 2025 | Annovis Bio Inc. | Open-market purchase | +415 | $4.14 | $1,718 |
| Nov 24, 2025 | Annovis Bio Inc. | Open-market purchase | +28,096 | $4.15 | $116,598 |
| Nov 21, 2025 | Annovis Bio Inc. | Open-market purchase | +10,000 | $3.49 | $34,900 |
| Nov 21, 2025 | Annovis Bio Inc. | Open-market purchase | +10,000 | $3.50 | $35,000 |
| Nov 14, 2025 | Annovis Bio Inc. | Open-market purchase | +15,000 | $2.11 | $31,650 |
| Oct 28, 2025 | Annovis Bio Inc. | Open-market purchase | +975,610 | $2.05 | $2,000,001 |
| Aug 29, 2025 | Annovis Bio Inc. | Grant or award | +5,000 | $2.28 | $11,400 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.